Literature summary extracted from
Alborn, W.E.; Cao, G.; Careskey, H.E.; Qian, Y.W.; Subramaniam, D.R.; Davies, J.; Conner, E.M.; Konrad, R.J.
Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol (2007), Clin. Chem., 53, 1814-1819.
Application
EC Number |
Application |
Comment |
Organism |
---|
3.4.21.61 |
medicine |
circulating concentrations of human PCSK9 are directly correlated with LDL and total cholesterol concentrations. PCSK9 is likely not associated with specific lipoprotein particles. Assay providing a means to tailor PCSK9-inhibitor therapy to patients most likely to respond to and benefit from pharmacologic inhibition of PCSK9 |
Homo sapiens |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
3.4.21.61 |
overexpressed in HEK-293 cells |
Homo sapiens |
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
3.4.21.61 |
Homo sapiens |
- |
- |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
3.4.21.61 |
by Ni-nitriloacetic acid and size-exclusion chromatography, more than 95% pure |
Homo sapiens |
Source Tissue
EC Number |
Source Tissue |
Comment |
Organism |
Textmining |
---|
3.4.21.61 |
serum |
concentrations of PCSK9 in serum vary considerably from person to person |
Homo sapiens |
- |
Storage Stability
EC Number |
Storage Stability |
Organism |
---|
3.4.21.61 |
-70°C |
Homo sapiens |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
3.4.21.61 |
PCSK9 |
- |
Homo sapiens |
3.4.21.61 |
proprotein convertase subtilisin kexin type 9 |
- |
Homo sapiens |